The 50th patient has been treated using the Epione robot from Quantum Surgical by the team of Laurent Milot, deputy chief vascular and interventional radiology at the Hospices Civils de Lyon (HCL; Lyon, France), highlighting a successful collaboration only eight months post-acquisition.
Installed in November 2022, the HCL team are convinced of the value of this platform from Quantum Surgical and celebrating that 50 patients have benefited from Epione. Epione can be used to treat early-stage abdominal tumours that are inoperable or particularly difficult to reach, due to their size or location.
HCL is the second hospital in the world offering this platform to their patients. The first Epione robot was acquired by the Institut Gustave Roussy (Villejuif, France) in January 2022 where the team has already treated more than 100 patients. The very first patient in the USA was also successfully treated using the Epione robot at Baptist Hospital in Miami (Miami, USA) last month.
Beyond the new procedural advantages it provides, Epione makes it possible to offer patients a minimally invasive treatment. It improves their comfort and facilitates their recovery, due to the absence of surgery.
For practitioners and hospitals, Epione combines advanced robotic assistance with image-guided navigation and ablation confirmation tools to promote the standardisation of minimally invasive tumour ablation procedures.
“I am very pleased with this milestone, which above all underlines the perfect match between the HCL teams and the Epione robot, which delivers all its promises. We are very excited to continue to explore the many benefits of Epione and to support the next steps in the development of robotics in interventional radiology. This will undoubtedly lead to significant progress and extend hope for patients we do not have treatment solutions for so far” explains Milot.
“The implementation of the Epione robot within the Hospices Civils de Lyon is a success: in eight months, 50 patients have already benefited from our technology, as part of their cancer treatment. Prof. Laurent Milot’s teams are particularly enthusiastic. We are delighted with this collaboration, which improves access to care and patient comfort” said Bertin Nahum, president and co-founder of Quantum Surgical.
